AGRX - アジャイル・セラピュ―ティクス (Agile Therapeutics Inc.)

AGRXのニュース

   Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022  2022/05/03 11:30:00 GlobeNewswire
Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET
   Agile Therapeutics to raise $13M in stock offering, provides certain Q1 estimates and reverse stock split effective Apr.27  2022/04/27 12:38:56 Seeking Alpha
Agile Therapeutics (AGRX) entered into a sales agreement to sell up to $12.84M of shares of stock, par value $0.0001/share, through a sales agent.The company cannot provide any…
   71 Biggest Movers From Yesterday  2022/04/27 08:27:24 Benzinga
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK ) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma''s Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults. Nutex Health, Inc. (NASDAQ: NUTX ) gained 73.8% to close at $7.68 on above-average volume despite no company-specific news. Cyngn Inc. (NASDAQ: CYN ) jumped 52.1% to close at $3.68 on above-average volume despite no company-specific news to justify the price action. Forge Global Holdings, Inc. (NYSE: FRGE ) gained 40.4% to close at $18.46 on above-average volume. GeoVax Labs, Inc. (NASDAQ: GOVX ) jumped 29.8% to settle at $1.11. The U.S. Patent and Trademark Office issued Patent No. 11,311,612 covering GeoVax Labs modified vaccinia Ankara (MVA) vector expressing certain antigens from the malaria parasite. Jiuzi Holdings, Inc. (NASDAQ: JZXN ) gained 27.3% to close at $1.68 after the company announced it entered into an equity acquisition agreement to acquire an automobile sales serviceshop operator under top china automaker Geely Auto''s premium electronic vehicle brand Geometry.
   Thinking about buying stock in Agile Therapeutics, Evoke Pharma, Warner Bros Discovery, Nkarta, or Sky Harbour?  2022/04/26 14:55:00 Benzinga
NEW YORK , April 26, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AGRX, EVOK, WBD, NKTX, and SKYH. … Full story available on Benzinga.com
   Agile Therapeutics stock gains on 1-for-40 reverse stock split  2022/04/26 12:13:49 Seeking Alpha
Agile Therapeutics (AGRX) shares surged ~30% pre-market after the women''s healthcare company announced a 1-for-40 reverse stock split, effective 5:00 p.m
   Analysts Provide Insight On How High Agile Therapeutics Inc. (AGRX) Can Go  2022/02/05 17:00:00 Stocks Register
Agile Therapeutics Inc. (NASDAQ:AGRX) concluded the trading at $0.35 on Friday, February 04 with a rise of 3.24% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.34 and 5Y monthly beta was reading 0.99 with its price kept floating in the … Analysts Provide Insight On How High Agile Therapeutics Inc. (AGRX) Can Go Read More »
   Agile Therapeutics Inc Shares Fall 3.0% Below Previous 52-Week Low - Market Mover  2022/01/15 13:45:43 Kwhen Finance
Agile Therapeutics Inc (AGRX) shares closed 3.0% lower than its previous 52 week low, giving the company a market cap of $48M. The stock is currently down 18.6% year-to-date, down 86.0% over the past 12 months, and down 84.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 77.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 3.9% lower than its 5-day moving average, 20.4% lower than its 20-day moving average, and 48.5% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1575.9% The company's stock price performance over the past 12 months lags the peer average by 1400.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Agile Therapeutics Inc Shares Near 52-Week Low - Market Mover  2022/01/14 04:59:14 Kwhen Finance
Agile Therapeutics Inc (AGRX) shares closed today at 1.6% above its 52 week low of $0.39, giving the company a market cap of $48M. The stock is currently down 18.7% year-to-date, down 86.2% over the past 12 months, and down 84.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 6.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -6080.5% The company's stock price performance over the past 12 months lags the peer average by 1933.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Agile Therapeutics Inc Shares Close in on 52-Week Low - Market Mover  2021/12/29 11:29:52 Kwhen Finance
Agile Therapeutics Inc (AGRX) shares closed today at 0.5% above its 52 week low of $0.50, giving the company a market cap of $61M. The stock is currently down 82.5% year-to-date, down 82.9% over the past 12 months, and down 91.8% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 4.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 13495.7% The company's stock price performance over the past 12 months lags the peer average by -24030.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   $1.76 Million in Sales Expected for Agile Therapeutics, Inc. (NASDAQ:AGRX) This Quarter  2021/12/22 19:44:44 Transcript Daily
Analysts expect Agile Therapeutics, Inc. (NASDAQ:AGRX) to report $1.76 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Agile Therapeutics earnings, with estimates ranging from $1.70 million to $1.81 million. Agile Therapeutics reported sales of $750,000.00 during the same quarter last year, which indicates a positive year []
   Analysts Provide Insight On How High Agile Therapeutics Inc. (AGRX) Can Go  2022/02/05 17:00:00 Stocks Register
Agile Therapeutics Inc. (NASDAQ:AGRX) concluded the trading at $0.35 on Friday, February 04 with a rise of 3.24% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.34 and 5Y monthly beta was reading 0.99 with its price kept floating in the … Analysts Provide Insight On How High Agile Therapeutics Inc. (AGRX) Can Go Read More »
   Agile Therapeutics Inc Shares Fall 3.0% Below Previous 52-Week Low - Market Mover  2022/01/15 13:45:43 Kwhen Finance
Agile Therapeutics Inc (AGRX) shares closed 3.0% lower than its previous 52 week low, giving the company a market cap of $48M. The stock is currently down 18.6% year-to-date, down 86.0% over the past 12 months, and down 84.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 77.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 3.9% lower than its 5-day moving average, 20.4% lower than its 20-day moving average, and 48.5% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1575.9% The company's stock price performance over the past 12 months lags the peer average by 1400.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Agile Therapeutics Inc Shares Near 52-Week Low - Market Mover  2022/01/14 04:59:14 Kwhen Finance
Agile Therapeutics Inc (AGRX) shares closed today at 1.6% above its 52 week low of $0.39, giving the company a market cap of $48M. The stock is currently down 18.7% year-to-date, down 86.2% over the past 12 months, and down 84.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 6.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -6080.5% The company's stock price performance over the past 12 months lags the peer average by 1933.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Agile Therapeutics Inc Shares Close in on 52-Week Low - Market Mover  2021/12/29 11:29:52 Kwhen Finance
Agile Therapeutics Inc (AGRX) shares closed today at 0.5% above its 52 week low of $0.50, giving the company a market cap of $61M. The stock is currently down 82.5% year-to-date, down 82.9% over the past 12 months, and down 91.8% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 4.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 13495.7% The company's stock price performance over the past 12 months lags the peer average by -24030.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   $1.76 Million in Sales Expected for Agile Therapeutics, Inc. (NASDAQ:AGRX) This Quarter  2021/12/22 19:44:44 Transcript Daily
Analysts expect Agile Therapeutics, Inc. (NASDAQ:AGRX) to report $1.76 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Agile Therapeutics earnings, with estimates ranging from $1.70 million to $1.81 million. Agile Therapeutics reported sales of $750,000.00 during the same quarter last year, which indicates a positive year []

calendar